A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 47/48 (2006.01)
Patent
CA 2102808
2102808 9220371 PCTABS00017 Methods and compositions for using conjugates of bone growth factors and targeting molecules in bone repair and augmentation are provided. The bone growth factor and targeting molecule are chemically conjugated to a crosslinker. The crosslinker is preferably a synthetic hydrophilic polymer. The bone growth factor is preferably TGF-.beta., activin, or bone morphogenic protein (BMP). Targeting molecules preferably have an affinity for bone, such as tetracycline, calcein, bisphosphonate, polyaspartic acid, polyglutamic acid, aminophosphosugars, or estrogen.
Bentz Hanne
Rosen David
Borden Ladner Gervais Llp
Celtrix Pharmaceuticals Inc.
LandOfFree
Targeted delivery of bone growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted delivery of bone growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted delivery of bone growth factors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1953400